What does CUSIP 79400X107 represent in this 13F holders report?

CUSIP 79400X107 is the security identifier for SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW in Q4 2020?

22 institutional investors reported SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW for Q4 2020. Use the holders table for investor-level position and value details.

SALARIUS PHARMACEUTICALS INC - COM NEW (SLRX)

CUSIP: 79400X107

Q4 2020 13F Holders as of 31 Dec 2020

Security type / class: Equity / COM NEW
Total 13F shares: 4,259,652
Total 13F value: $3,876,000
Share change: +1,988,275
SEC-reported price per share: $0.91
Number of holders: 22
Value change: +$1,808,246
Number of buys: 9
Number of sells: 4

Security key

79400X107

Report period

Q4 2020

Institutions

Top holders

SLRX full security history Ownership snapshot Full 13F holder table Decoy Therapeutics Inc. SEC filings Decoy Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Worth Venture Partners, LLC

Disclosed value leader

Worth Venture Partners, LLC

Comparable rows

0/15

Latest evidence

30 Sep 2020

13F Highest disclosed value: $218,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Worth Venture Partners, LLC has the largest disclosed position value at $218K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Worth Venture Partners, LLC's linked filing trail.

Disclosed position value Top 5

Worth Venture Partners, LLC $218K

Kepos Capital LP $105K

Douglass Winthrop Advisors, LLC $67K

Tower Research Capital LLC (TRC) $44K

Bank of New York Mellon Corp $38K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Worth Venture Partners, LLC	13F Company 13F	— denominator unverified	$218,000 258,249 shares	—	30 Sep 2020
Kepos Capital LP	13F Company 13F	— denominator unverified	$105,000 125,000 shares	—	30 Sep 2020
Douglass Winthrop Advisors, LLC	13F Company 13F	— denominator unverified	$67,000 78,806 shares	—	30 Sep 2020
Tower Research Capital LLC (TRC)	13F Company 13F	— denominator unverified	$44,000 52,619 shares	—	30 Sep 2020
Bank of New York Mellon Corp	13F Company 13F	— denominator unverified	$38,000 45,007 shares	—	30 Sep 2020
Laird Norton Wetherby Wealth Management, LLC	13F Company 13F	— denominator unverified	$34,000 39,746 shares	—	30 Sep 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

4,259,652

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 value	Q4 2020 value	Value change	Value Chg %